EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cardiovascular Risk in Women With Nonclassical Congenital Adrenal Hyperplasia

Fernanda Cavalieri Costa iD, Larissa Garcia Gomes iD, Thais Martins de Lima iD, Luiz Aparecido Bortolotto iD, Valeria Hong iD, Renata Verardino iD, Manoel de Souza Rocha iD, Serli Kiyomi Nakao Ueda iD, Mirela Costa de Miranda iD, Heraldo Possolo de Souza iD, Ana Claudia Latronico iD, Berenice Bilharinho Mendonca iD und 1 weitere

The Journal of Clinical Endocrinology & Metabolism · 2024

DOI: 10.1210/clinem/dgae155 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2024. Verfasst von Fernanda Cavalieri Costa und 12 weiteren Autor:innen. Beteiligte Einrichtung: Laboratório de Hormônios e Genética Molecular- LIM/42, Departamento de Clínica Médica, Disciplina de Endocrinologia e Metabologia, Unidade de Adrenal…. Hauptthemen laut MEDLINE: Adrenal Hyperplasia, Congenital, Cardiovascular Diseases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: FAPESP (Fundação de Amparo à Pesquisa do Estado de São Paulo), CNPq (Conselho Nacional de Desenvolvimento Científico e Tecnológico).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

The outcomes related to cardiovascular risk (CVR) in patients with the nonclassical form of congenital adrenal hyperplasia (NCAH) are unknown, especially those related to therapeutic options, including low doses of glucocorticoids or oral contraceptive pills.

Objectives

To analyze CVR by markers of atherosclerosis in females with the nonclassical form according to therapeutic options. Design and Setting A cross-sectional study at a tertiary center. Patients and Methods Forty-seven females with NCAH (33.4 ± 10 years) were subdivided into group 1 (G1) (n = 28) treated with dexamethasone (0.14 ± 0.05 mg/m2/day), group 2 (G2) (n = 19) treated with oral contraceptive pills, and group 3 (G3) (30 matched controls). CVR was analyzed through serum lipids, the Homeostatic Model Assessment for Insulin Resistance (HOMA-IR), inflammatory cytokines levels, and quantitative image evaluations [pulse wave velocity (PWV), endothelial function by flow-mediated dilatation (FMD), carotid intima media thickness (CIMT), and visceral fat (VAT) by abdominal tomography].

Results

There were no statistically significant differences in BMI, HOMA-IR, high-density lipoprotein-cholesterol, or triglyceride levels among groups (P > .05). Serum interleukin 6 (IL-6) levels were higher in G1 than in G2 (P = .048), and interleukin 8 (IL-8) levels were higher in G1 than in G2/3 (P = .008). There were no statistically significant differences in VAT, PWV, FMD, or CIMT among groups (P > .05). In multivariable regression analysis, there was no statistically significant association between glucocorticoid dose and evaluated outcomes.

Conclusion

Adult females with NCAH did not show increased CVR using methodologies for detection of precocious atherosclerosis. Although patients receiving dexamethasone therapy had increased IL-6 and IL-8 levels, these data were not associated with radiological markers of atherosclerosis. Our cohort was composed of young adults and should be reevaluated in a long-term follow-up.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adrenal Hyperplasia, CongenitalCardiovascular DiseasesHumansFemaleCross-Sectional StudiesAdultYoung AdultHeart Disease Risk FactorsCarotid Intima-Media ThicknessDexamethasoneGlucocorticoidsMiddle AgedBiomarkersAtherosclerosisInsulin ResistanceContraceptives, Oral

Stichwörter der Autor:innen

cardiovascular riskcarotid intima media thicknessendothelial functionnonclassical congenital adrenal hyperplasiapulse wave velocityvisceral fat

Substanzen

DexamethasoneGlucocorticoidsBiomarkersContraceptives, Oral

Autor:innen und Institutionen

  • Laboratório de Hormônios e Genética Molecular- LIM/42, Departamento de Clínica Médica, Disciplina de Endocrinologia e Metabologia, Unidade de Adrenal, Hospital das Clínicas, Faculdade de Medicina da Universidade de São…
  • Laboratório de Emergências Clínicas (LIM 51), Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo, 05403-000 São Paulo, Brazil.
  • Instituto do Coração (INCOR), Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, 05403-000 São Paulo, Brasil.
  • Instituto de Radiologia, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, 05403-000 São Paulo, Brazil.

ORCID-Profile: Fernanda Cavalieri Costa, Larissa Garcia Gomes, Thais Martins de Lima, Luiz Aparecido Bortolotto, Valeria Hong, Renata Verardino, Manoel de Souza Rocha, Serli Kiyomi Nakao Ueda, Mirela Costa de Miranda, Heraldo Possolo de Souza, Ana Claudia Latronico, Berenice Bilharinho Mendonca, Tania A S S Bachega

Förderung

  • FAPESP (Fundação de Amparo à Pesquisa do Estado de São Paulo)
  • CNPq (Conselho Nacional de Desenvolvimento Científico e Tecnológico)

Zitieren

APA

Costa, F. C., Gomes, L. G., de Lima, T. M., Bortolotto, L. A., Hong, V., Verardino, R., de Souza Rocha, M., Ueda, S. K. N., de Miranda, M. C., de Souza, H. P., Latronico, A. C., Mendonca, B. B., & Bachega, T. A. S. S. (2024). Cardiovascular Risk in Women With Nonclassical Congenital Adrenal Hyperplasia. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgae155

Vancouver

Costa FC, Gomes LG, de Lima TM, Bortolotto LA, Hong V, Verardino R, et al. Cardiovascular Risk in Women With Nonclassical Congenital Adrenal Hyperplasia. The Journal of Clinical Endocrinology & Metabolism. 2024. doi:10.1210/clinem/dgae155

BibTeX
@article{Costa2024,
  author = {Costa, Fernanda Cavalieri and Gomes, Larissa Garcia and de Lima, Thais Martins and Bortolotto, Luiz Aparecido and Hong, Valeria and Verardino, Renata and de Souza Rocha, Manoel and Ueda, Serli Kiyomi Nakao and de Miranda, Mirela Costa and de Souza, Heraldo Possolo and Latronico, Ana Claudia and Mendonca, Berenice Bilharinho and Bachega, Tania A S S},
  title = {Cardiovascular Risk in Women With Nonclassical Congenital Adrenal Hyperplasia},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2024},
  doi = {10.1210/clinem/dgae155}
}
Kostenlos starten →